Pun Patrick H
Division of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, NC.
Adv Chronic Kidney Dis. 2014 Nov;21(6):480-8. doi: 10.1053/j.ackd.2014.06.007. Epub 2014 Oct 24.
CKD patients face an increased risk of cardiovascular disease mortality, and the risk of sudden cardiac death (SCD) increases as kidney function declines. Risk factors for SCD are poorly understood and understudied among CKD patients. In the general population, coronary heart disease-associated risk factors are the most important determinants of SCD risk, but among CKD patients, there is evidence that these factors play a much smaller role. Complex relationships between CKD-specific risk factors, structural heart disease, and arrhythmic triggers contribute to the high risk of SCD and ventricular arrhythmias and modulate the effectiveness of available therapies. This review examines recent data on the epidemiology, pathophysiology, and mechanisms of SCD among CKD patients and examines current evidence regarding the use of pharmacologic and device-based therapies for management of SCD risk.
慢性肾脏病(CKD)患者面临心血管疾病死亡风险增加,且心脏性猝死(SCD)风险随肾功能下降而升高。在CKD患者中,SCD的危险因素了解甚少且研究不足。在一般人群中,冠心病相关危险因素是SCD风险的最重要决定因素,但在CKD患者中,有证据表明这些因素的作用要小得多。CKD特异性危险因素、结构性心脏病和心律失常触发因素之间的复杂关系导致了SCD和室性心律失常的高风险,并调节了现有治疗方法的有效性。本综述研究了CKD患者中SCD的流行病学、病理生理学和机制的最新数据,并审视了关于使用药物和基于器械的疗法来管理SCD风险的现有证据。